downsides of semaglutide Comparative safety and side effects and tirzepatide: Implications for clinical decision-making in obesity management What is Semaglutide? Benefits and

Metabolic rate generally tracks with body weight

References SURMOUNT-5 head-to-head trial (NEJM, May 2025) summary via American College of Cardiology: SURPASS-2 primary publication (NEJM, 2021): Eli Lilly SURMOUNT-1 results announcement (NEJM data): Insights into the Mechanism of Action of Tirzepatide (PMC narrative review): Tirzepatide is an imbalanced and biased dual GIP/GLP-1 receptor agonist (PMC): SURMOUNT-5 GI tolerability / discontinuation data (Applied Clinical Trials, tctmd, DiabetesontheNet coverage): SURMOUNT-1 to -4 GI tolerability (Rubino 2025, Diabetes Obesity & Metabolism): Community sentiment context Reddit GLP-1 side-effect analysis and comparative meta-analyses (PMC): Research Use Only Notice: The content on this page is provided for informational and educational purposes only

In other words, youll want to make sure the new compounded semaglutide product comes from a reliable provider

Based on clinical trials and user reviews, you should expect to lose about 10% of your body weight at 6 months and 15% of your body weight at 1 year

Contact your healthcare provider if you experience persistent or severe abdominal discomfort